Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Niagen Bioscience, Inc. has filed 979 SEC EDGAR filings since 18 Jan 2007

SEC filing history

Showing 851-875 of 926 matching filings.

Per page
25
Current page
35
4

4 filing

Filing date
12 May 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-172882

CHROMADEX 10Q APR 2 2011

Filing date
12 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53290

CHROMADEX 10Q APR 2 2011

Filing date
12 May 2011
Reporting date
02 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-53290

DEFINITIVE PROXY STATEMENT

Filing date
11 Apr 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53290

8-K filing

Filing date
04 Apr 2011
Reporting date
30 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
31 Mar 2011
Reporting date
30 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-172882

EFFECT filing

Filing date
24 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-172882

CHROMADEX CORPORATION FORM S-1

Filing date
16 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-168916

PROSPECTUS SUPPLEMENT NO. 2

Filing date
16 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-53290

FORM 10-K

Filing date
16 Mar 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53290

8-K filing

Filing date
04 Mar 2011
Reporting date
02 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
03 Mar 2011
Reporting date
20 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Feb 2011
Reporting date
04 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Feb 2011
Reporting date
02 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2011
Reporting date
31 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84250

SC 13G filing

Filing date
28 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-84250

SC 13D filing

Filing date
19 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-84250

SC 13G/A filing

Filing date
17 Dec 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Nov 2010
Reporting date
22 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2010
Reporting date
15 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .